FindTrial
Sign In

Structured Weight Loss Program

BEHAVIORAL3 trials

Sponsors

Stanford University, University of Alabama at Birmingham, The Methodist Hospital Research Institute

Conditions

Endometrial Atypical HyperplasiaEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial NeoplasiaEndometrial CancerEndometrial Cancer Stage IFertility-Sparing Treatment (FST)MiscarriageObeseObesity

Phase 2

Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
Not yet recruitingNCT07820358
The Methodist Hospital Research InstituteEndometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial Cancer +3
Start: 2027-01-01End: 2031-12-31Target: 48Updated: 2026-09-15

Unknown Phase

Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss
TerminatedNCT01325805
Stanford UniversityMiscarriage, Obese, Overweight +1
Start: 2010-12-31End: 2013-12-31Updated: 2022-01-03
Effect of Time-Restricted Feeding on Fat Loss and Cardiometabolic Risk Factors in Overweight Adults
CompletedNCT03459703
University of Alabama at BirminghamObesity
Start: 2018-07-12End: 2020-04-30Updated: 2020-07-08

Related Papers

Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity
JAMA Internal Medicine2022-08-08237 citations